A carregar...
Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events
Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) have transformed the treatment landscape in front-line and recurrent high-grade serous ovarian cancer. Maintenance strategies with PARPi have been assessed in randomized phase III trials in ovarian cancer; switch maintenance in the case of olapa...
Na minha lista:
| Publicado no: | Int J Gynecol Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398227/ https://ncbi.nlm.nih.gov/pubmed/32276934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ijgc-2020-001288 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|